Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 461Neoplasms 378Carcinoma, Non-Small-Cell Lung 354Prostatic Neoplasms 294Colorectal Neoplasms 257Lung Neoplasms 225Multiple Myeloma 206Neoplasm Metastasis 164Pancreatic Neoplasms 156Leukemia, Myeloid, Acute 153Ovarian Neoplasms 136Squamous Cell Carcinoma of Head and Neck 130Melanoma 116Carcinoma, Renal Cell 103Stomach Neoplasms 102Carcinoma, Hepatocellular 100Recurrence 98Lymphoma 94Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Head and Neck Neoplasms 91Lymphoma, Non-Hodgkin 86Glioblastoma 85Brain Neoplasms 84Hematologic Neoplasms 83Urinary Bladder Neoplasms 82Triple Negative Breast Neoplasms 81Endometrial Neoplasms 80Lymphoma, Large B-Cell, Diffuse 79Leukemia, Lymphocytic, Chronic, B-Cell 77Uterine Cervical Neoplasms 74

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Hyperplasia × 30 days × Clear all
NCT04879940 2026-05-20

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
17 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT06511141 2026-05-12

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Axonics, Inc.

Phase NA Recruiting
150 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder, Overactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡